Antiviral effect of strictinin on influenza virus replication

Antiviral Research

Volumn 88, Issue 1, 2010, Pages 10-18

  Saha, Repon Kumer ^a   Takahashi, Tadanobu ^a   Kurebayashi, Yuuki ^a   Fukushima, Keijo ^a   Minami, Akira ^a   Kinbara, Noriaki ^b   Ichitani, Masaki ^b   Sagesaka, Yuko M ^b   Suzuki, Takashi ^a  

^a UNIVERSITY OF SHIZUOKA   (Japan)

^b 421 0516   (Japan)

Author keywords

Antiviral; Influenza; Parainfluenza; Strictinin; Viral entry; Virus

Indexed keywords

AMANTADINE; STRICTININ; TANNIN; UNCLASSIFIED DRUG; VIRUS SIALIDASE;

ANTIVIRAL ACTIVITY; ARTICLE; DRUG CYTOTOXICITY; DRUG STRUCTURE; IC 50; INFLUENZA VIRUS; NONHUMAN; PARAINFLUENZA VIRUS; PRIORITY JOURNAL; VIRUS ENTRY; VIRUS INHIBITION; VIRUS PLAQUE; VIRUS REPLICATION;

ANIMALS; ANTIVIRAL AGENTS; CELL LINE; DOSE-RESPONSE RELATIONSHIP, DRUG; HUMANS; INFLUENZA A VIRUS; INFLUENZA B VIRUS; NEURAMINIDASE; PARAINFLUENZA VIRUS 1, HUMAN; PHENOLS; TANNINS; VIRUS ATTACHMENT; VIRUS REPLICATION;

HUMAN PARAINFLUENZA VIRUS 1; INFLUENZA A VIRUS; INFLUENZA B VIRUS; ORTHOMYXOVIRIDAE; SUIDAE;

EID: 77956917225     PISSN: 01663542     EISSN: 18729096     Source Type: Journal    
DOI: 10.1016/j.antiviral.2010.06.008     Document Type: Article

References (47)

1. Bastow K.F., Bori I.D., Fukushima Y., Kashiwada Y., Tanaka T., Nonaka G., Nishioka I., Lee K.H. Inhibition of DNA topoisomerases by sanguiin H-6, a cytotoxic dimeric ellagitannin from Sanguisorba officinalis. Planta Med. 1993, 59:240-245.
2. Bouvier N.M., Lowen A.C., Palese P. Oseltamivir-resistant influenza A viruses are transmitted efficiently among guinea pigs by direct contact but not by aerosol. J. Virol. 2008, 82:10052-10058.
3. Bui M., Wills E., Helenius A., Whittaker G.R. The role of influenza virus M1 in nuclear export of viral RNPs. J. Virol. 2000, 74:1781-1786.
4. Carr J., Ives J., Kelly L., Lambkin R., Oxford J., Mendel D., Tai L., Roberts N. Influenza virus carrying neuraminidase with reduced sensitivity to oseltamivir carboxylate has altered properties in vitro and is compromised for infectivity and replicative ability in vivo. Antiviral Res. 2002, 54:79-88.
5. Centers for Disease Control and Prevention (CDC) High levels of adamantane resistance among influenza A (H3N2) viruses and interim guidelines for use of antiviral agents - United States, 2005-06 influenza season. MMWR Morb. Mortal. Wkly. Rep. 2006, 20:44-46.
6. Cheong H.J. Novel influenza A (H1N1): where are we?. J. Korean Med. Sci. 2009, 24:361-362.
7. Colman P.M. A novel approach to antiviral therapy for influenza. J. Antimicrob. Chemother. 1999, 44:17-22.
8. Conyers S.M., Kidwell D.A. Chromogenic substrates for horseradish peroxidase. Anal. Biochem. 1991, 192:207-211.
9. De Clercq E. Antiviral drugs in current clinical use. J. Clin. Virol. 2004, 30:115-133.
10. Deyde V.M., Nguyen T., Bright R.A., Balish A., Shu B., Lindstrom S., Klimov A.I., Gubareva L.V. Detection of molecular markers of antiviral resistance in influenza A (H5N1) viruses using a pyrosequencing method. Antimicrob. Agents Chemother. 2009, 53:1039-1047.
11. Fukuchi K., Sakagami H., Okuda T., Hatano T., Tanuma S., Kitajima K., Inoue Y., Inoue S., Ichikawa S., Nonoyama M., et al. Inhibition of herpes simplex virus infection by tannins and related compounds. Antiviral Res. 1989, 11:285-297.
12. Gao D.F., Zhang Y.J., Yang C.R., Chen K.K., Jiang H.J. Phenolic antioxidants from green tea produced from Camellia taliensis. J. Agric. Food Chem. 2008, 56:7517-7521.
13. Gubareva L.V., Kaiser L., Matrosovich M.N., Soo-Hoo Y., Hayden F.G. Selection of influenza virus mutants in experimentally infected volunteers treated with oseltamivir. J. Infect. Dis. 2001, 183:523-531.
14. Hara Y. Green Tea: Health Benefits and Applications 2001, CRC Press, New York.
15. Haslam E. Natural polyphenols (vegetable tannins) as drugs: possible modes of action. J. Nat. Prod. 1996, 59:205-215.
16. Hayden F.G., Hay A.J. Emergence and transmission of IAVes resistant to amantadine and rimantadine. Curr. Top. Microbiol. Immunol. 1992, 176:119-130.
17. Hurt A.C., Ernest J., Deng Y.M., Iannello P., Besselaar T.G., Birch C., Buchy P., Chittaganpitch M., Chiu S.C., Dwyer D., Guigon A., Harrower B., Kei I.P., Kok T., Lin C., McPhie K., Mohd A., Olveda R., Panayotou T., Rawlinson W., Scott L., Smith D., D'Souza H., Komadina N., Shaw R., Kelso A., Barr I.G. Emergence and spread of oseltamivir-resistant A(H1N1) influenza viruses in Oceania, South East Asia and South Africa. Antiviral Res. 2009, 83:90-93.
18. Kashiwada Y., Nonaka G., Nishioka I., Chang J.J., Lee K.H. Antitumor agents, 129. Tannins and related compounds as selective cytotoxic agents. J. Nat. Prod. 1992, 55:1033-1043.
19. Kato N., Eggers H.J. Inhibition of uncoating of fowl plague virus by l-adamantanamine hydrochloride. Virology 1969, 37:632-641.
20. Khurana S., Suguitan A.L., Rivera Y., Simmons C.P., Lanzavecchia A., Sallusto F., Manischewitz J., King L.R., Subbarao K., Golding H. Antigenic fingerprinting of H5N1 avian influenza using convalescent sera and monoclonal antibodies reveals potential vaccine and diagnostic targets. PLoS Med. 2009, 21:e1000049.
21. Lamb R.A., Pinto L.H. Do Vpu and Vpr of human immunodeficiency virus type 1 and NB of influenza B virus have ion channel activities in the virus life cycles?. Virology 1997, 229:1-11.
22. Li Z.N., Lee B.J., Langley W.A., Bradley K.C., Russell R.J., Steinhauer D.A. Length requirements for membrane fusion of influenza virus hemagglutinin peptide linkers to transmembrane or fusion peptide domains. J. Virol. 2008, 82:6337-6348.
23. Martin K., Helenius A. Nuclear transport of influenza virus ribonucleoproteins: the viral matrix protein (M1) promotes export and inhibits import. Cell 1991, 67:117-130.
24. Matrosovich M.N., Matrosovich T.Y., Gray T., Roberts N.A., Klenk H.D. Neuraminidase is important for the initiation of influenza virus infection in human airway epithelium. J. Virol. 2004, 78:12665-12667.
25. Monobe M., Ema K., Kato F., Maeda-Yamamoto M. Immunostimulating activity of a crude polysaccharide derived from green tea (Camellia sinensis) extract. J. Agric. Food Chem. 2008, 27:1423-1427.
26. Moore J.P., Doms R.W. The entry of entry inhibitors: a fusion of science and medicine. Proc. Natl. Acad. Sci. U.S.A. 2003, 100:10598-10602.
27. Moscona A. Entry of parainfluenza virus into cells as a target for interrupting childhood respiratory disease. J. Clin. Invest. 2005, 115:1688-1689.
28. Mosmann T. Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J. Immunol. Methods 1983, 16:55-63.
29. Nakayama M., Suzuki K., Toda M., Okubo S., Hara Y., Shimamura T. Inhibition of the infectivity of influenza virus by tea polyphenols. Antiviral Res. 1993, 21:289-299.
30. Ng T.B., Huang B., Fong W.P., Yeung H.W. Anti-human immunodeficiency virus (anti-HIV) natural products with special emphasis on HIV reverse transcriptase inhibitors. Life Sci. 1997, 61:933-949.
31. Niino H., Sakane I., Okanoya K., Kuribayashi S., Kinugasa H. Determination of mechanism of flock sediment formation in tea beverages. J. Agric. Food Chem. 2005, 18:3995-3999.
32. Nonaka G., Kawahara O., Nishioka I. Tannins and related compounds. XV. A new class of dimeric flavan-3-ol gallates, theasinensins A and B, and proanthocyanidin gallates from green tea leaf. Chem. Pharm. Bull. 1983, 31:3906-3914.
33. Okuda T. Systematics and health effects of chemically distinct tannins in medicinal plants. Phytochemistry 2005, 66:2012-2031.
34. Quideau S., Feldman S. Ellagitannin chemistry. Chem. Rev. 1996, 86:475-503.
35. Saha R.K., Takahashi T., Suzuki T. Glucosyl hesperidin prevents influenza A virus replication in vitro by inhibition of viral sialidase. Biol. Pharm. Bull. 2009, 32:1188-1192.
36. Song J.M., Lee K.H., Seong B.L. Antiviral effect of catechins in green tea on influenza virus. Antiviral Res. 2005, 68:66-74.
37. Suzuki T., Ikeda K., Koyama N., Hosokawa C., Takahashi T., Hidari I.-P., Jawa K., Miyamoto D., Guo C.-T., Tanaka K., Suzuki Y. Inhibition of human parainfluenza virus type 1 neuraminidase by analogues of 2-deoxy-2,3-didehydro-N-acetyl-neuraminic acid. Glycoconjugate J. 2001, 18:331-337.
38. Suzuki T., Portner A., Scroggs R.A., Uchikawa M., Koyama N., Matsuo K., Suzuki Y., Takimoto T. Receptor specificities of human respiroviruses. J. Virol. 2001, 75:4604-4613.
39. Suzuki T., Takahashi T., Guo C.T., Hidari K.I., Miyamoto D., Goto H., Kawaoka Y., Suzuki Y. Sialidase activity of influenza A virus in a endocytic pathway enhances viral replication. J. Virol. 2005, 79:11705-11715.
40. Suzuki Y., Suzuki T., Matsumoto M. Isolation and characterization of receptor sialoglycoprotein for hemagglutinating virus of Japan (Sendai virus) from bovine erythrocyte membrane. J. Biochem. 1983, 93:1621-1633.
41. Suzuki Y., Nakao T., Ito T., Watanabe N., Toda Y., Xu G., Suzuki T., Kobayashi T., Kimura Y., Yamada A. Structural determination of gangliosides that bind to influenza A, B, and C viruses by an improved binding assay: strain-specific receptor epitopes in sialo-sugar chains. Virology 1992, 189:121-131.
42. Tachibana H., Kubo T., Miyase T., Tanino S., Yoshimoto M., Sano M., Maeda-Yamamoto M., Yamada K. Identification of an inhibitor for interleukin 4-induced epsilon germline transcription and antigen-specific IgE production in vivo. Biochem. Biophys. Res. Commun. 2001, 280:53-60.
43. Takahashi T., Murakami K., Nagakura M., Kishita H., Watanabe S., Honke K., Ogura K., Tai T., Kawasaki K., Miyamoto D., Hidari K.I., Guo C.T., Suzuki Y., Suzuki T. Sulfatide is required for efficient replication of Influenza A Virus. J. Virol. 2008, 82:5940-5950.
44. WHO Pandemic Influenza Preparedness and Response 2009, http://www.who.int/csr/disease/influenza/pipguidance2009/en/.
45. Wiley D.C., Skehel J.J. The structure and function of the hemagglutinin membrane glycoprotein of influenza virus. Annu. Rev. Biochem. 1987, 56:365-394.
46. Yagi K., Goto K., Nanjo F. Identification of a major polyphenol and polyphenolic composition in leaves of Camellia irrawadiensis. Chem. Pharm. Bull. (Tokyo) 2009, 57:1284-1289.
47. Zhou B., Yang L., Liu Z.-L. Strictinin as an efficient antioxidant in lipid peroxidation. Chem. Phys. Lipids 2004, 131:15-25.